Kerianne McKeon, PA
Medical · Portland, ORNPI 1831346717
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,714 of the $2,000 with a category attached, or 85.7%. 16 manufacturers reported payments, led by Pfizer at 24.3% of the total.
Across 101 payments — averaging $19.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$485
- Johnson & Johnson$401
- Sanofi$230
- AbbVie$211
- Lilly USA, LLC$189
- Sanofi-aventis U.S. LLC$99
- plus $384 from 10 others
What the payments were for
- Food & beverage$1,71486%
- Education$28514%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 35 | $485 |
| Johnson & Johnson | 14 | $401 |
| Sanofi | 9 | $230 |
| AbbVie | 10 | $211 |
| Lilly USA, LLC | 11 | $189 |
| Sanofi-aventis U.S. LLC | 1 | $99 |
| UCB, Inc. | 4 | $76 |
| Regeneron Healthcare Solutions, Inc. | 3 | $56 |
| E.r. Squibb & Sons, L.L.C. | 2 | $52 |
| Amgen | 3 | $43 |
| Galderma Laboratories, L.p. | 2 | $37 |
| Organon | 2 | $31 |
| Novartis | 2 | $31 |
| Boehringer Ingelheim | 1 | $25 |
| Dermavant Sciences, Inc. | 1 | $18 |
| Sun Pharmaceutical Industries Inc. | 1 | $16 |
How this compares
$2,000 in reported general payments places this provider in the 85th percentile of 364 medical providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Minoxidil | 322 | $3,716 |
| Ketoconazole | 273 | $3,467 |
| Clobetasol Propionate | 101 | $3,408 |
| Doxycycline Hyclate | 48 | $2,314 |
| Hydroxychloroquine Sulfate | 37 | $1,651 |
| Finasteride | 127 | $1,029 |
| Spironolactone | 29 | $665 |
| Betamethasone Valerate | 20 | $577 |
| Betamethasone Dipropionate | 13 | $352 |
| Ciclopirox | 16 | $314 |
| Triamcinolone Acetonide | 25 | $200 |
| MethotrexateMethotrexate Sodium | 12 | $161 |
| Hydrocortisone | 18 | $124 |
Paid to pharmacies, not to this prescriber.
Other medical in Portland
- Britt BennPortland$11K
- Erica BallardPortland$8K
- Kimberly SandersPortland$5K
- Cody BallardPortland$4K
- Margaret NgPortland$4K
- Dmitriy ShorePortland$3K
- Bridget LahmPortland$3K
- Mary TeggerPortland$3K
- Maureen BaileyPortland$3K
- Kelly WulfPortland$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.